Phenotype switching in melanoma: Implications for progression and therapy
Version 3 2024-06-19, 05:18
Version 2 2024-06-04, 14:51
Version 1 2023-02-01, 00:29
journal contribution
posted on 2024-06-19, 05:18 authored by FZ Li, Amardeep DhillonAmardeep Dhillon, RL Anderson, G McArthur, PT FerraoPhenotype switching in melanoma: Implications for progression and therapy
History
Related Materials
- 1.
Location
SwitzerlandLink to full text
Language
EnglishPublication classification
CN.1 Other journal articleJournal
Frontiers in OncologyVolume
5Article number
ARTN 31ISSN
2234-943XeISSN
2234-943XIssue
FEBPublisher
FRONTIERS MEDIA SAUsage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicineOncologymelanomaphenotype switchingEMTmetastasisRTK signalingBRAF inhibitionresistanceEPITHELIAL-MESENCHYMAL-TRANSITIONTRANSCRIPTION FACTOR SNAILBRAF INHIBITOR RESISTANCEE-CADHERIN EXPRESSIONTUMOR PROGRESSIONTGF-BETASIGNALING PATHWAYMASTER REGULATORGENE-EXPRESSIONCELLS
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC